Minimal Residual Disease in Head and Neck Cancer: Molecular Surveillance and Clinical Action.
Sensitive blood tests detect cancer recurrence in head and neck patients months before standard imaging does.
This PubMed record reports recurrence following curative-intent treatment for head and neck squamous cell carcinoma (HNSCC) approaches 50% in locally advanced disease, yet conventional surveillance detects relapse only after anatomical or metabolic thresholds are reached. The study was classified as validation study and is relevant to early detection.
What the study was
- Study design
- Validation study
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Current oncology reports
Why it surfaced
Conservative triage based on the PubMed abstract, validation study, clinical relevance, and unmet-need signals.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.